Advertisement

Topics

Athera Biotechnologies & ALPCO Company Profile

18:57 EST 17th February 2018 | BioPortfolio

Athera has a unique and in-depth understanding of the immunological components in atherosclerosis, the inflammatory process leading to cardiovascular disease (CVD). The company currently has two biopharmaceutical product candidates aimed at treating patients with acute heart conditions and a biomarker linked to the therapeutic approach. Athera is a Karolinska Development AB (publ) portfolio company and is also a major partner in the highly ranked EU-project CVDIMMUNE, which also includes Karolinska Institute, Imperial College London, Phadia GmbH and TNO.


News Articles [90 Associated News Articles listed on BioPortfolio]

Athera Biotechnologies Initiates Phase IIa Trial On Arterial Inflammation With Its Antibody PC-mAb

Athera initiates Phase 2a trial on arterial inflammation with its antibody PC-mAb Stockholm October 11, 2017 Athera Biotechnologies AB today announced that screening has started for a Phase 2a prospec...

Athera Biotechnologies Allowed US Composition Of Matter Patents For Therapeutic Antibodies

  Life Sciences Jobs   ...

Athera Biotechnologies Concludes Follow-Up Visits In Multiple Dosing Trial With Its Immunovascular Antibody

  Life Sciences Jobs   ...

Athera raises SEK57M

#jobs #lifescience FUJIFILM Diosynth Biotechnologies: Principal Scientist (Analytical Development) x 2

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: FUJIFILM Diosynth Biotechnologies: Principal Scientist (Analytical Developmen...

Athera begins Phase IIa trial of PC-mAb for arterial inflammation

Athera Biotechnologies AB Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14112017] Prices from USD $250

SummaryAthera Biotechnologies AB Athera is a biopharmaceutical company that develops targeted anti inflammatory biological candidate drugs and companion diagnostics for cardiovascular disease. The com...

Fujifilm Diosynth Biotechnologies opens new UK lab

Fujifilm Diosynth Biotechnologies has opened a $9m process development laboratory in Teeside, UK.

Drugs and Medications [0 Results]

None

PubMed Articles [14 Associated PubMed Articles listed on BioPortfolio]

Ethical principles for the use of human cellular biotechnologies.

Rebooting Bioresilience: A Multi-OMICS Approach to Tackle Global Catastrophic Biological Risks and Next-Generation Biothreats.

Global Catastrophic Biological Risks (GCBRs) refer to biological events-natural, deliberate, and accidental-of a global and lasting impact. This challenges the life scientists to raise their game on t...

Is De-extinction Special?

I have been involved with the current interest in de-extinction since early 2012, nearly its beginning. I have given a lot of thought to the potential risks and benefits of de-extinction. But only rec...

Technologies for the bioconversion of methane into more valuable products.

Methane, with a global warming potential twenty five times higher than that of CO2 is the second most important greenhouse gas emitted nowadays. Its bioconversion into microbial molecules with a high ...

Overcoming the energetic limitations of syngas fermentation.

The fermentation of synthesis gas (including carbon monoxide, carbon dioxide, and hydrogen) with anaerobic acetogens is an established biotechnological process that has recently been transferred to a ...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

ALPCO Calprotectin ELISA - Measurement of Calprotectin Levels in Human Stool

The ALPCO Calprotectin ELISA is an in vitro diagnostic test intended to quantitatively measure concentrations of fecal calprotectin in human stool samples. Calprotectin is a protein biomar...

Companies [105 Associated Companies listed on BioPortfolio]

Athera Biotechnologies & ALPCO

Athera has a unique and in-depth understanding of the immunological components in atherosclerosis, the inflammatory process leading to cardiovascular disease (CVD). The company currently has two b...

Athera Biotechnologies AB

Athera has a unique and in-depth understanding of the immunological components in atherosclerosis, the inflammatory process leading to cardiovascular disease (CVD). The company currently has two b...

RAN Biotechnologies

Based in Beverly, MA, USA, RAN Biotechnologies, Inc., www.ranbiotechnologies.com, provides chemicals specially optimized for microfluidic and biotechnological applications. Partic...

ALPCO

ALPCO Diagnostics

More Information about "Athera Biotechnologies & ALPCO" on BioPortfolio

We have published hundreds of Athera Biotechnologies & ALPCO news stories on BioPortfolio along with dozens of Athera Biotechnologies & ALPCO Clinical Trials and PubMed Articles about Athera Biotechnologies & ALPCO for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Athera Biotechnologies & ALPCO Companies in our database. You can also find out about relevant Athera Biotechnologies & ALPCO Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...


Corporate Database Quicklinks



Searches Linking to this Company Record